Severe and Asymptomatic Data Could Give Moderna’s COVID-19 Vaccine Slight Edge Over Pfizer’s

 
• By Sarah Karlin-Smith
  
Moderna logo and syringe (Alex Gottschalk/DeFodi Images via Getty Images)
• Source: Alex Gottschalk/DeFodi Images via Getty Images
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet